OverviewSuggest Edit

Oxford Nanopore Technologies is a company that develops nanopore-based electronic systems for analysis of single molecules, including DNA, RNA, and proteins. It offers the handheld MinION device as well as the PromethION and GridION systems designed to provide qualities in molecular sensing such as real-time data streaming, scalability of workflows, and direct analysis of the molecule of interest. The devices are used in scientific research, personalized medicine, crop science, security and defense, and environmental applications.
TypePrivate
Founded2005
HQOxford, GB
Websitenanoporetech.com
Employee Ratings3.8

Latest Updates

Employees (est.) (Sept 2021)629(+3%)
Job Openings57
Revenue (FY, 2020)£113.9 M(+119%)
Cybersecurity ratingCMore

Key People/Management at Oxford Nanopore Technologies

Gordon Sanghera

Gordon Sanghera

Chief Executive Officer and Director
Spike Willcocks

Spike Willcocks

Chief BD Officer and Director
John Schoellerman

John Schoellerman

SVP, Corporate Development and Investment
Zoe McDougall

Zoe McDougall

VP, Marketing and Corporate Affairs
Tim Cowper

Tim Cowper

CFO, Director
Clive Brown

Clive Brown

Chief Technology Officer and Director
Show more

Oxford Nanopore Technologies Office Locations

Oxford Nanopore Technologies has offices in Oxford, Didcot, Harwell, Little Chesterford and in 7 other locations
Oxford, GB (HQ)
Gosling Building, Edmund Halley Rd, Littlemore
Didcot, GB
HQ Building, Thomson Avenue, Harwell, Campus
Harwell, GB
Rutherford Appleton Laboratories Building R70, Room 5
Little Chesterford, GB
Science Village Building Chesterford Research Park
Beijing, CN
1 Jianguomen Outer St, Guo Mao, Chaoyang Qu
Shanghai, CN
Office Tower I, 1 Hongqiao Rd, Xu Jia Hui, Xuhui Qu
Show all (11)

Oxford Nanopore Technologies Financials and Metrics

Summary Metrics

Founding Date

2005

Oxford Nanopore Technologies total Funding

$1.3 b

Oxford Nanopore Technologies latest funding size

$271.12 m

Time since last funding

5 months ago

Oxford Nanopore Technologies investors

Oxford Nanopore Technologies's latest funding round in May 2021 was reported to be $271.1 m. In total, Oxford Nanopore Technologies has raised $1.3 b. Oxford Nanopore Technologies's latest valuation is reported to be $1.6 b.
View all funding rounds

Oxford Nanopore Technologies Revenue

Embed Graph
View revenue for all periods
Oxford Nanopore Technologies's revenue was reported to be £113.86 m in FY, 2020 which is a 118.7% increase from the previous period.
GBP

Revenue (FY, 2020)

113.9m

Revenue growth (FY, 2019 - FY, 2020), %

118.7%

Gross profit (FY, 2020)

46.9m

Gross profit margin (FY, 2020), %

41.2%

Net income (FY, 2020)

(61.2m)

EBIT (FY, 2020)

(73.1m)

Market valuation

1.6b

Cash (31-Dec-2020)

80.9m

EV

1.5b
GBPFY, 2018FY, 2019FY, 2020

Revenue

32.5m52.1m113.9m

Revenue growth, %

60%119%

Cost of goods sold

16.5m26.4m67.0m

Gross profit

16.0m25.6m46.9m
GBPFY, 2018FY, 2019FY, 2020

Cash

35.3m13.1m80.9m

Accounts Receivable

10.6m14.1m49.0m

Prepaid Expenses

6.0m4.8m10.8m

Inventories

18.6m20.0m35.6m
GBPFY, 2018FY, 2019FY, 2020

Depreciation and Amortization

6.4m12.8m15.0m

Inventories

(12.2m)(1.4m)(15.6m)

Accounts Payable

6.5m12.8m33.7m

Cash From Operating Activities

(56.1m)(48.7m)(63.8m)
GBPFY, 2018

Revenue/Employee

108.2k

Debt/Equity

0.1 x

Debt/Assets

0.1 x

Financial Leverage

1.2 x
Show all financial metrics

Oxford Nanopore Technologies Operating Metrics

Sep, 2021

Patents and Patent Applications

2 k
Show all operating metrics

Oxford Nanopore Technologies Acquisitions / Subsidiaries

Company NameDateDeal Size
KK Oxford Nanopore Diagnostics Limited
Metrichor Limited
Nanopore Technologies (Shanghai) Co. Limited
Oxford Nanolabs Limited
Oxford Nanopore Technologies Australia PTY Ltd
Oxford Nanopore Technologies BV
Oxford Nanopore Technologies Denmark ApS
Oxford Nanopore Technologies, Inc.
Oxford Nanopore Technologies SARL
Oxford Nanopore Technologies Singapore PTE Ltd
Show more

Oxford Nanopore Technologies Revenue Breakdown

Embed Graph

Oxford Nanopore Technologies revenue breakdown by business segment: 93.1% from Sale of Goods and 6.9% from Other

Oxford Nanopore Technologies revenue breakdown by geographic segment: 14.4% from USA, 16.6% from Europe, 6.8% from China, 46.4% from UK, 12.1% from Rest of World and 3.7% from Other

Oxford Nanopore Technologies Cybersecurity Score

Cybersecurity ratingPremium dataset

C

73/100

SecurityScorecard logo

Oxford Nanopore Technologies Online and Social Media Presence

Embed Graph

Oxford Nanopore Technologies News and Updates

Global $12.7 Billion Pharmacogenomics Markets to 2026 with Profiles of Abbott Laboratories, GlaxoSmithKline, Johnson & Johnson, Novartis, Oxford Nanopore Technologies and Thermo Fisher Scientific

Dublin, May 11, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmacogenomics Market 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Oxford Nanopore Technologies Blogs

IPO Microsite

IPO Microsite James.Merner@n… Thu, 09/09/2021 - 11:06 Access the Oxford Nanopore IPO microsite. IPO Microsite

Workflow: Metagenomic assembly

Workflow: Metagenomic assembly katarina.nice@… Wed, 09/08/2021 - 11:48 Assembling microbial genomes from complex metagenomic samples using long nanopore reads Covering a vast array of applications, metagenomic sequencing allows the rapid identification and analysis of culturable micro…

Application note: Optimising read length for human genome sequencing

Application note: Optimising read length for human genome sequencing jessica.davies… Thu, 07/01/2021 - 13:17 Introduction The ability to obtain sequencing reads of any length with nanopore technology, whilst maintaining base modification information, provides a unique opportunity to a…

Intraoperative DNA methylation classification of brain tumors impacts neurosurgical strategy

Intraoperative DNA methylation classification of brain tumors impacts neurosurgical strategy 549660843 daphne.peart@n… Fri, 05/21/2021 - 14:59 Luna Djirackor works at the Oslo University Hospital, Norway, where her team see about 300 adults and 30 children with brain…

Oxford Nanopore Tech Update: new Duplex method for Q30 nanopore single molecule reads, PromethION 2, and more

Oxford Nanopore Tech Update: new Duplex method for Q30 nanopore single molecule reads, PromethION 2, and more sarah.foxton@n… Fri, 05/21/2021 - 14:59 In a technical update at the London Calling 2021 conference, Oxford Nanopore provided an overview of recent platform advances, includin…

Complete vertebrate mitogenomes reveal widespread repeats and gene duplications

Complete vertebrate mitogenomes reveal widespread repeats and gene duplications jordan.coady@n… Fri, 04/30/2021 - 15:31
Show more

Oxford Nanopore Technologies Frequently Asked Questions

  • When was Oxford Nanopore Technologies founded?

    Oxford Nanopore Technologies was founded in 2005.

  • Who are Oxford Nanopore Technologies key executives?

    Oxford Nanopore Technologies's key executives are Gordon Sanghera, Spike Willcocks and John Schoellerman.

  • How many employees does Oxford Nanopore Technologies have?

    Oxford Nanopore Technologies has 629 employees.

  • What is Oxford Nanopore Technologies revenue?

    Latest Oxford Nanopore Technologies annual revenue is £113.9 m.

  • What is Oxford Nanopore Technologies revenue per employee?

    Latest Oxford Nanopore Technologies revenue per employee is £181 k.

  • Who are Oxford Nanopore Technologies competitors?

    Competitors of Oxford Nanopore Technologies include Illumina, 10X Genomics and Pacific Biosciences of California.

  • Where is Oxford Nanopore Technologies headquarters?

    Oxford Nanopore Technologies headquarters is located at Gosling Building, Edmund Halley Rd, Littlemore, Oxford.

  • Where are Oxford Nanopore Technologies offices?

    Oxford Nanopore Technologies has offices in Oxford, Didcot, Harwell, Little Chesterford and in 7 other locations.

  • How many offices does Oxford Nanopore Technologies have?

    Oxford Nanopore Technologies has 11 offices.